Targeted CRO partner Certus International operates as an integrated Contract Research Organization and Imaging Core Lab with extensive trial management, consulting and imaging services. This positions them as a potential partner for sponsors seeking end-to-end clinical trial support, offering opportunities to upsell additional imaging, data management, and regulatory consulting services.

FDA relationship leverage The company emphasizes maintaining an excellent working relationship with the FDA and tailoring trials to sponsor needs based on vast trial experience. This suggests a competitive edge in navigating regulatory pathways and could be leveraged to offer expedited regulatory consulting, risk-based monitoring, and streamlined submissions.

Flexible, client-centric With a flat organizational structure and real-person phone support, Certus highlights strong customer service and responsiveness. This can be pitched to sponsors seeking high-touch, low-friction collaboration, offering premium account management and faster decision cycles.

Imaging and core lab strength As an Imaging Core Lab service provider in addition to CRO capabilities, Certus can cross-sell advanced imaging analytics, centralized image review, and bespoke imaging endpoints to trials requiring robust imaging data for efficacy and safety assessments.

Growth upside amid peers With annual revenue in the mid-range for mid-sized CROs and a workforce of 51-200, Certus sits between small agile shops and large global firms. This positioning creates a sales opening to attract sponsors seeking cost-effective, scalable CRO services with personalized attention, and potential expansion into broader therapeutic areas.